Very interestingly, it was recently reported that CRC patient-derived xenografts contain a sub-population of cancer stem cells characterized by high expression levels of the RNA pol I subunit A (PolR1A) and elevated biosynthetic capacities [191]. Here, POLR1A is linked to colorectal carcinoma.